Video

ONC-CHAT: 'VOGL, NEW YORK' on 10 Years of Tamoxifen


 

"VOGL, NEW YORK" is how Dr. Steven Vogl identifies himself when he stands up at major oncology meetings. He is by now well known for his pointed questions, and received a plaque at the 2010 San Antonio Breast Cancer Symposium in recognition of his unique contribution. Here is his take on a major study presented in 2012.

Recommended Reading

San Antonio Breast Cancer Symposium: More to Come on 2011 Practice Changers
MDedge ObGyn
More Bevacizumab Trials to Report Outcomes in San Antonio
MDedge ObGyn
Dr. C. Kent Osborne Previews the San Antonio Breast Cancer Symposium
MDedge ObGyn
Surviving breast cancer shouldn't mean relinquishing intimacy
MDedge ObGyn
Breast Cancer: Molecular Profiling Doesn't Trump Standard Pathology
MDedge ObGyn
Experimental Drug Puts ER-Positive Breast Cancer on Hold
MDedge ObGyn
Less Invasive Biopsy Used Less in Black Breast Cancer Patients
MDedge ObGyn
Ten Years of Adjuvant Tamoxifen Found Superior to Five
MDedge ObGyn
Mammograms Dip in Wake of USPSTF Recommendations
MDedge ObGyn
PET/CT Pinpoints Physiological Evidence of Chemo Brain
MDedge ObGyn